Atlas Trials

NeurAxon Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch NeurAxon Inc.

RecordFirmDate
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia (NCT01748877)NeurAxon Inc.2013-01-01
Study of the Safety and Effectiveness of NXN-188 for the Treatment of Migraine Headache Without Aura (NCT00959751)NeurAxon Inc.2009-07-01
Study of NXN 188 for the Treatment of Migraine With Aura (NCT00920686)NeurAxon Inc.2009-06-01

Track NeurAxon Inc. automatically

Every clearance here is in the API, with alerts when new ones post.